Everolimus

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9484 publications

Retraction: Potentiation of the anticancer effects of everolimus using a dual mTORC1/2 inhibitor in hepatocellular carcinoma cells.

Retraction: Potentiation of the anticancer effects of everolimus using a dual mTORC1/2 inhibitor in hepatocellular carcinoma cells.

Journal: Oncotarget
Published: September 08, 2026

Sacituzumab govitecan in ER+/HER2- breast cancer: a necessary treatment option for patients who have undergone multiple prior treatments.

Sacituzumab govitecan in ER+/HER2- breast cancer: a necessary treatment option for patients who have undergone multiple prior treatments.

Journal: Recenti progressi in medicina
Published: September 02, 2026

Efficacy and safety of everolimus in heart transplant recipients: A meta-analysis.

Efficacy and safety of everolimus in heart transplant recipients: A meta-analysis.

Journal: JHLT open
Published: August 27, 2026

Acute Bilateral Vocal Cord Immobility Secondary to Acute Myopathy.

Acute Bilateral Vocal Cord Immobility Secondary to Acute Myopathy.

Journal: Ear, nose, & throat journal
Published: August 25, 2026

Everolimus Breast Milk Transfer After Liver Transplantation.

Everolimus Breast Milk Transfer After Liver Transplantation.

Journal: Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine
Published: August 24, 2026

FBXO6 ubiquitinates MAOA to promote monoamine neurotransmitter accumulation and tumor growth in HCC.

FBXO6 ubiquitinates MAOA to promote monoamine neurotransmitter accumulation and tumor growth in HCC.

Journal: Journal of molecular cell biology
Published: August 17, 2026

Latest Classification and Management of Circumscribed Astrocytic Gliomas

Latest Classification and Management of Circumscribed Astrocytic Gliomas

Journal: No shinkei geka. Neurological surgery
Published: August 16, 2026

Everolimus inhibits malignant phenotype of erdafitinib-resistant bladder cancer cells through the p70S6K/PI3K/MAPK signaling pathway

Everolimus inhibits malignant phenotype of erdafitinib-resistant bladder cancer cells through the p70S6K/PI3K/MAPK signaling pathway

Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University
Published: August 11, 2026

Cutaneous Manifestations of Carcinoid Tumor and Syndrome.

Cutaneous Manifestations of Carcinoid Tumor and Syndrome.

Journal: Clinics in dermatology
Published: August 04, 2026

Dementia as a rare neurological adverse event of Nivolumab in a patient with metastatic renal cell carcinoma.

Dementia as a rare neurological adverse event of Nivolumab in a patient with metastatic renal cell carcinoma.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: July 30, 2026

Prenatal mTOR-Inhibitor Therapy for Fetal Cardiac Rhabdomyomas: Indications, Treatment Duration and Perinatal Outcomes.

Prenatal mTOR-Inhibitor Therapy for Fetal Cardiac Rhabdomyomas: Indications, Treatment Duration and Perinatal Outcomes.

Journal: Journal of clinical medicine
Published: July 19, 2026

Engineering CAR T Cells for Hepatocellular Carcinoma Recurrence after Liver Transplantation.

Engineering CAR T Cells for Hepatocellular Carcinoma Recurrence after Liver Transplantation.

Journal: bioRxiv : the preprint server for biology
Published: July 10, 2026
Showing 1-12 of 9,484

Last Updated: 09/26/2026